US · 4 sources covering this

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

4 L · 0 C · 0 R

How 4 sources are covering this

The HinduLean L·2h ago
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Read at The Hindu →
The HinduLean L·

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/d59f6e945920d1c4878083469e4b55cd3fb88369"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma"></iframe>

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

How 4 sources are covering this

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

More from US

OnePlus Nord 6 gets big price drop

Samsung Galaxy S25 FE now available at a lower price

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

Samsung Galaxy S25 Ultra price drops to lowest

iPhone 17 price drops under Rs 71,000, here is the deal

Reader

Trust & legal

Across the network